Tivenix SA and CellCarta Biosciences Announce Expanded Strategic Partnership to Advance Epigenetic Liquid Biopsy Services. Building on a collaboration initiated in 2025, the partnership expands to encompass clinical development programs in the US and globally, and a joint commercial offering

        Montreal, Canada & Lugano, Switzerland — July 21, 2025 – CellCarta, a global leader in precision medicine laboratory services, today announced a strategic partnership with Tivenix, a precision diagnostics company focused on neurodegenerative diseases. The

We are thrilled to announce that Miro Venturi has joined Tivenix SA as a board member! Miro brings a wealth of experience and expertise to our team, and we’re incredibly excited to have him on board. His strategic vision and

This is a significant milestone in our journey, as it will provide us with valuable support and guidance to further enhance our product and business. It also marks a motivating second endorsement of our hard work, building on the innovation